Further studies are undergoing to confirm the relevance of the MyD88-dependent LPS/Tlr4 pathway in inducing LPS-induced defects at the EBIS such that therapies targeted at blocking LPS signaling for the management of infection-induced early pregnancy disorders can be found. This evidence concerns the gene MYD88 and pregnancy disorder.